Open Access. Powered by Scholars. Published by Universities.®
Other Immunology and Infectious Disease Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medicine and Health Sciences (3)
- Infectious Disease (2)
- Medical Specialties (2)
- Public Health (2)
- COVID-19 (1)
-
- Clinical Epidemiology (1)
- Diseases (1)
- Environmental Education (1)
- Environmental Health and Protection (1)
- Environmental Sciences (1)
- Health Law and Policy (1)
- Immunology of Infectious Disease (1)
- Immunopathology (1)
- Influenza Virus Vaccines (1)
- Law (1)
- Physical Sciences and Mathematics (1)
- Virus Diseases (1)
- Institution
- Publication
- Publication Type
Articles 1 - 4 of 4
Full-Text Articles in Other Immunology and Infectious Disease
Antibody Duration After Infection From Sars-Cov-2 In The Texas Coronavirus Antibody Response Survey, Michael D Swartz, Stacia M Desantis, Ashraf Yaseen, Frances A Brito, Melissa A Valerio-Shewmaker, Sarah E Messiah, Luis G Leon-Novelo, Harold W Kohl, Cesar L Pinzon-Gomez, Tianyao Hao, Shiming Zhang, Yashar Talebi, Joy Yoo, Jessica R Ross, Michael O Gonzalez, Leqing Wu, Steven H Kelder, Mark Silberman, Samantha Tuzo, Stephen J Pont, Jennifer A Shuford, David Lakey, Eric Boerwinkle
Antibody Duration After Infection From Sars-Cov-2 In The Texas Coronavirus Antibody Response Survey, Michael D Swartz, Stacia M Desantis, Ashraf Yaseen, Frances A Brito, Melissa A Valerio-Shewmaker, Sarah E Messiah, Luis G Leon-Novelo, Harold W Kohl, Cesar L Pinzon-Gomez, Tianyao Hao, Shiming Zhang, Yashar Talebi, Joy Yoo, Jessica R Ross, Michael O Gonzalez, Leqing Wu, Steven H Kelder, Mark Silberman, Samantha Tuzo, Stephen J Pont, Jennifer A Shuford, David Lakey, Eric Boerwinkle
Faculty, Staff and Student Publications
Understanding the duration of antibodies to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that causes COVID-19 is important to controlling the current pandemic. Participants from the Texas Coronavirus Antibody Response Survey (Texas CARES) with at least 1 nucleocapsid protein antibody test were selected for a longitudinal analysis of antibody duration. A linear mixed model was fit to data from participants (n = 4553) with 1 to 3 antibody tests over 11 months (1 October 2020 to 16 September 2021), and models fit showed that expected antibody response after COVID-19 infection robustly increases for 100 days postinfection, and predicts …
Media Analysis Of Coverage Of Environmental Issues In The Midst Of A Pandemic, Alexandria N. Miller, Lucia A. Bolles
Media Analysis Of Coverage Of Environmental Issues In The Midst Of A Pandemic, Alexandria N. Miller, Lucia A. Bolles
Thinking Matters Symposium
This research aimed to answer the question “has the coronavirus impacted the print media’s coverage of important environmental issues?” The research analyzed 2 different print newspapers - The New York Times and the Wall Street Journal - to determine if there was a change in coverage of environmental news as the coronavirus spread in the US. Data for stories published in the first four days of every month from March through September was compiled for 2019 and 2020. Our findings showed a 78.85% decrease in coverage of environmental issues between 2019 and 2020 when stories related to the coronavirus pandemic …
A General Pathological Outlook Of Covid-19, Shadman Shaikh
A General Pathological Outlook Of Covid-19, Shadman Shaikh
Honor’s College Freeman Research Journal
The COVID-19 pandemic has been expressed as one of the world’s most fatal pandemics in recent human history, and with good reason. At the time of this writing, over 125 million global cases have been confirmed, with a death toll rate sitting at 2.5 million. From the moment the pandemic was announced globally, the international scientific community sought out to analyze more about the virus in the hopes to find a cure. It should be imperative to analyze this virus in all aspects, including recent treatment efforts. Doing so will allow us to not only understand as to how this …
Why The Government Shouldn't Pay People To Get Vaccinated Against Covid-19, Ana Santos Rutschman
Why The Government Shouldn't Pay People To Get Vaccinated Against Covid-19, Ana Santos Rutschman
All Faculty Scholarship
As several pharmaceutical companies approach the Food and Drug Administration (FDA) seeking authorization to bring COVID-19 vaccines to market, concerns about vaccine mistrust cloud the prospects of imminent vaccination efforts across the globe. These concerns have prompted some commentators to suggest that governments may nudge vaccine uptake by paying people to get vaccinated against COVID-19. This post argues that, even if potentially viable, this idea is undesirable against the backdrop of a pandemic marked by the intertwined phenomena of health misinformation and mistrust in public health authorities. Even beyond the context of COVID-19, paying for vaccination is likely to remain …